Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Oct;34(1):55–61. doi: 10.1128/iai.34.1.55-61.1981

Effect of immunization on the genesis of pneumococcal endocarditis in rabbits.

S W Adler 2nd, D S Selinger, W P Reed
PMCID: PMC350820  PMID: 7298192

Abstract

The effect of immunization with whole organisms on the development of Streptococcus pneumoniae endocarditis was examined by in vivo and in vitro methods. Immunization protected rabbits from pneumococcal endocarditis when the in vivo catheterization model was used. The inoculum size that caused endocarditis in 50% of the unimmunized rabbits was 1.1 X 10(5) colony-forming units, whereas 1.2 X 10(7) colony-forming units were required for infecting 50% of the immunized rabbits (P less than 0.001). Investigations were carried out to determine the mechanism which enabled immunization to prevent the development of pneumococcal endocarditis; they indicated that a reduction in bacterial adherence could not explain this phenomenon. In vitro studies showed that subagglutinating quantities of antibody increased the adherence (P less than 0.05) of pneumococci to rabbit aortic valve cusps. The adherence ratio of pneumococci to fibrin-platelet clots was at least doubled by the presence of subagglutinating dilutions of immune sera (P less than 0.001). Further studies showed that immunoglobulin G in the immune sera accounted for this increased in vitro adherence. However, further in vivo studies showed that immunized rabbits were able to clear live pneumococci from their bloodstreams within 4.5 h, whereas unimmunized rabbits failed to clear the organism within 24 h.

Full text

PDF
60

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer G. L., Johnston J. L. Effect of type-specific active immunization on the development and progression of experimental Pseudomonas aeruginosa endocarditis. Infect Immun. 1979 Apr;24(1):167–173. doi: 10.1128/iai.24.1.167-173.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baker R. F., Loosli C. G. The ultrastructure of encapsulated Diplococcus pneumoniae type 1 before and after exposure to type specific antibody. Lab Invest. 1966 Apr;15(4):716–730. [PubMed] [Google Scholar]
  3. Durack D. T., Gilliland B. C., Petersdorf R. G. Effect of immunization on susceptibility to experimental Streptococcus mutans and Streptococcus sanguis endocarditis. Infect Immun. 1978 Oct;22(1):52–56. doi: 10.1128/iai.22.1.52-56.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Finland M., Barnes M. W. Changing etiology of bacterial endocarditis in the antibacterial era. Experiences at Boston City Hospital 1933-1965. Ann Intern Med. 1970 Mar;72(3):341–348. doi: 10.7326/0003-4819-72-3-341. [DOI] [PubMed] [Google Scholar]
  5. HSU K. C., RIFKIND R. A., ZABRISKIE J. B. FLUORESCENT, ELECTRON MICROSCOPIC, AND IMMUNOELECTROPHORETIC STUDIES OF LABELED ANTIBODIES. Science. 1963 Dec 13;142(3598):1471–1473. doi: 10.1126/science.142.3598.1471. [DOI] [PubMed] [Google Scholar]
  6. Maisch P. A., Calderone R. A. Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro. Infect Immun. 1980 Feb;27(2):650–656. doi: 10.1128/iai.27.2.650-656.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Miller J. K. Meningococcal Endocarditis in Immunized Horses. Am J Pathol. 1944 Mar;20(2):269–276. [PMC free article] [PubMed] [Google Scholar]
  8. RUEGSEGGER J. M. Pneumococcal endocarditis. Am Heart J. 1958 Dec;56(6):867–877. doi: 10.1016/0002-8703(58)90195-9. [DOI] [PubMed] [Google Scholar]
  9. Reed W. P., Jaffee P., Albright E. L., Williams R. C., Jr Effect of intravenously injected killed pneumococci on leukocytes, complement, and phagocytosis in rabbits. Infect Immun. 1980 Sep;29(3):1021–1027. doi: 10.1128/iai.29.3.1021-1027.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sande M. A., Johnson M. L. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. J Infect Dis. 1975 Apr;131(4):367–375. doi: 10.1093/infdis/131.4.367. [DOI] [PubMed] [Google Scholar]
  11. Scheld W. M., Thomas J. H., Sande M. A. Influence of preformed antibody on experimental Streptococcus sanguis endocarditis. Infect Immun. 1979 Sep;25(3):781–785. doi: 10.1128/iai.25.3.781-785.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Scheld W. M., Valone J. A., Sande M. A. Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest. 1978 May;61(5):1394–1404. doi: 10.1172/JCI109057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Thörig L., Thompson J., van Furth R. Effects of immunization and anticoagulation on the development of experimental Escherichia coli endocarditis. Infect Immun. 1980 May;28(2):325–330. doi: 10.1128/iai.28.2.325-330.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Weinstein L., Schlesinger J. J. Pathoanatomic, pathophysiologic and clinical correlations in endocarditis (first of two parts). N Engl J Med. 1974 Oct 17;291(16):832–837. doi: 10.1056/NEJM197410172911609. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES